Ma Yingli 内部人交易：近期 SEC Form 4 交易
过去 18 个月，Ma Yingli（CIK 1963664）在 1 家公司共报告 5 笔 SEC Form 4 内部人交易（最近一笔 2026-03-23）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-03-23 | Structure Therapeutics Inc. (GPCR) | CHIEF TECHNOLOGY OFFICER | 买入 | 32,526 | $0 |
| 2026-03-05 | Structure Therapeutics Inc. (GPCR) | CHIEF TECHNOLOGY OFFICER | 卖出 | 11,313 | $237,460 |
| 2025-08-20 | Structure Therapeutics Inc. (GPCR) | CHIEF TECHNOLOGY OFFICER | 卖出 | 4,470 | $30,575 |
| 2025-07-03 | Structure Therapeutics Inc. (GPCR) | CHIEF TECHNOLOGY OFFICER | 卖出 | 1,824 | $14,446 |
| 2025-07-03 | Structure Therapeutics Inc. (GPCR) | CHIEF TECHNOLOGY OFFICER | 买入 | 24,459 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-03-23